Skip to main content

Investigation of the MSC Paracrine Effects on Alveolar–Capillary Barrier Integrity in the In Vitro Models of ARDS

  • Protocol
  • First Online:
In Vitro Models for Stem Cell Therapy

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2269))

Abstract

Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical disorder with high mortality rates and no specific pharmacological treatment available yet. It is characterized by excessive inflammation in the alveolar compartment resulting in edema of the airspaces due to loss of integrity in the alveolar epithelial–endothelial barrier leading to the development of hypoxemia and often severe respiratory failure. Changes in the permeability of the alveolar epithelial–endothelial barrier contribute to excessive inflammation, the formation of lung edema and impairment of the alveolar fluid clearance. In recent years, Mesenchymal Stromal Cells (MSCs) have attracted attention as a cell therapy for ARDS. MSCs are known to secrete a variety of biologically active factors (growth factors, cytokines, and extracellular vesicles). These paracrine factors have been shown to be major effectors of the anti-inflammatory and regenerative properties observed in multiple in vitro and in vivo studies. This chapter provides a simple protocol on how to investigate the paracrine effect of MSCs on the alveolar epithelial–endothelial barrier functions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. de Castro LL, Lopes-Pacheco M, Weiss DJ et al (2019) Current understanding of the immunosuppressive properties of mesenchymal stromal cells. J Mol Med Ther Ber 97(5):605–618

    Article  Google Scholar 

  2. Fergie N, Todd N, McClements L et al (2019) Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair. FASEB J 33(4):5585–5598

    Article  CAS  Google Scholar 

  3. Morrison TJ, Jackson MV, Cunningham EK et al (2017) Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med 196(10):1275–1286

    Article  CAS  Google Scholar 

  4. Jackson MV, Morrison TJ, Doherty DF et al (2016) Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 34(8):2210–2223

    Article  CAS  Google Scholar 

  5. Silva JD, Lopes-Pacheco M, Paz AHR et al (2018) Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome. Crit Care Med 46(2):e132–e140

    Article  Google Scholar 

  6. Maron-Gutierrez T, Silva JD, Asensi KD et al (2013) Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice. Crit Care Med 41(11):e319–e333

    Article  Google Scholar 

  7. Brown C, McKee C, Bakshi S et al (2019) Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regen Med 13(9):1738–1755

    Article  CAS  Google Scholar 

  8. Murray LM, Krasnodembskaya AD (2019) Concise review:intercellular communication via organelle transfer in biology and therapeutic applications of stem cells. Stem Cells 37(1):14–25

    Article  Google Scholar 

  9. Weiss DJ, English K, Krasnodembskaya A et al (2019) The necrobiology of mesenchymal stromal cells affects therapeutic efficacy. Front Immunol 10:1228. https://doi.org/10.3389/fimmu.2019.01228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ware LB, Bastarache JA, Bernard GR (2017) Acute respiratory distress syndrome. In: Vincent J-L et al (eds) Textbook of critical care, 7th edn. Elsevier, Philadelphia, pp 413–424

    Google Scholar 

  11. Lee JW, Fang X, Gupta N et al (2009) Allogeneic human mesenchymal stem cells for the treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 106(38):16,357–16,362

    Article  CAS  Google Scholar 

  12. X1 F, Neyrinck AP, Matthay MA, Lee JW (2010) Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 285(34):26211–26222

    Google Scholar 

  13. Islam MN, Das SR, Emin MT et al (2012) Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 18(5):759–765

    Article  CAS  Google Scholar 

  14. Miller I, Min M, Yang C et al (2018) Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep 24(5):1105–1112.e5

    Article  CAS  Google Scholar 

  15. Samary CS, Ramos AB, Maia LA et al (2018) Focal ischemic stroke leads to lung injury and reduces alveolar macrophage phagocytic capability in rats. Crit Care 22(1):249

    Article  Google Scholar 

  16. Abreu SC, Antunes MA, Xisto DG et al (2017) Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma. Stem Cells Transl Med 6(6):1557–1567

    Article  CAS  Google Scholar 

  17. Buachan P, Chularojmontri L, Wattanapitayakul S (2014) Selected activities of Citrus Maxima merr. Fruits on human endothelial cells: enhancing cell migration and delaying cellular aging. Nutrients 6:1618–1634

    Article  CAS  Google Scholar 

  18. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317

    Article  CAS  Google Scholar 

  19. Théry C, Witwer KW, Aikawa E et al (2018) Minimal information for studies of extracellular vesicles (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna D. Krasnodembskaya .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Silva, J.D., Krasnodembskaya, A.D. (2021). Investigation of the MSC Paracrine Effects on Alveolar–Capillary Barrier Integrity in the In Vitro Models of ARDS. In: Stock, P., Christ, B. (eds) In Vitro Models for Stem Cell Therapy. Methods in Molecular Biology, vol 2269. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1225-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1225-5_5

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1224-8

  • Online ISBN: 978-1-0716-1225-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics